NCT01568996View on ClinicalTrials.gov

Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Atypical NeviMelanoma
Interventions
DRUG

broccoli sprout extract - sulforaphane (BSE-SFN)

50 µmol capsules, taken orally, once a day for 28 days

DRUG

broccoli sprout extract - sulforaphane (BSE-SFN)

100 µmol capsules, taken orally, once a day for 28 days

DRUG

broccoli sprout extract - sulforaphane (BSE-SFN)

200 µmol capsules, taken orally, once a day for 28 days

Trial Locations (1)

15232

UPMC Hillman Cancer Center, Pittsburgh

All Listed Sponsors
lead

John Kirkwood

OTHER

NCT01568996 - Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions | Biotech Hunter | Biotech Hunter